Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Growth and Treatment in Congenital Adrenal Hyperplasia: An Observational Study from Diagnosis to Final Height.

Hormone research in paediatrics - 1 Jan 2024

Gidlöf Sebastian, Hogling Daniel Eriksson, Lönnberg Hanna, Ritzén Martin, Lajic Svetlana, Nordenström Anna

Abstract excerpt

INTRODUCTION: Congenital adrenal hyperplasia (CAH) due to 21α-hydroxylase deficiency results in inadequate cortisol and aldosterone synthesis and concomitant overproduction of adrenal androgens. Despite adequate replacement, impaired growth and overweight remain a clinical challenge. The main objective was to investigate the differences in growth, final height (FH), and body mass index (BMI) between different...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adrenal Hyperplasia, Congenital
Share to Body Height

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Body Mass Index

Share to Child, Preschool

Share to Glucocorticoids

Share to Infant

Share to Steroid 21-Hydroxylase

Share to Sweden

Source

Open in PubMed Open full text

Identifiers

PMID: 38016434
DOI: 10.1159/000535403
PMCID: PMC11446323

Genes

FH
CYP21A2

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Growth and Treatment in Congenital Adrenal Hyperplasia: An Observational Study from Diagnosis to Final Height.PMID 38016434Read ↗

Final height in congenital adrenal hyperplasia due to 21-hydroxylase deficiency: the Italian experience.Semantic proximity Read ↗

Newborn screening-detected 21-hydroxylase deficiency: growth pattern is not associated with the genotype.Semantic proximity Read ↗

Growth analysis in patients with 21-hydroxylase deficiency influence of glucocorticoid dosage, age at diagnosis, phenotype and genotype on growth and height outcome.Semantic proximity Read ↗

CYP21 genotype, adult height, and pubertal development in 55 patients treated for 21-hydroxylase deficiency.Semantic proximity Read ↗

Genotype-phenotype correlation in 153 adult patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency: analysis of the United Kingdom Congenital adrenal Hyperplasia Adult Study Executive (CaHASE) cohort.Semantic proximity Read ↗

Clinical, biochemical and genetic features with nonclassical 21-hydroxylase deficiency and final height.Semantic proximity Read ↗

Adult height of subjects with nonclassical 21-hydroxylase deficiency.Semantic proximity Read ↗

Cardiovascular risk, metabolic profile, and body composition in adult males with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.Semantic proximity Read ↗

Increased Cardiovascular and Metabolic Morbidity in Patients With 21-Hydroxylase Deficiency: A Swedish Population-Based National Cohort Study.Semantic proximity Read ↗

Bone mineral density, bone markers, and fractures in adult males with congenital adrenal hyperplasia.Semantic proximity Read ↗

Genotype-Specific Cortisol Reserve in a Cohort of Subjects With Nonclassic Congenital Adrenal Hyperplasia (NCCAH).Semantic proximity Read ↗

Growth patterns in the first three years of life in children with classical congenital adrenal hyperplasia diagnosed by newborn screening and treated with low doses of hydrocortisone.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.